Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 6 Fib (1.1-1.5 g/L) level before and after treatment (mean ± SD)

		Fib (g/L)	PT (s)	PLT (109/L)	TBIL (μmol/L)	ALB (g/L)
Research group 30 cases	Before treatment	1.25 ± 0.13	22.27 ± 2.18	59.87 ± 29.90	129.71 ± 95.70	31.74 ± 4.69
	After treatment	1.72 ± 0.33	18.45 ± 2.11	59.50 ± 27.86	46.75 ± 19.83	36.46 ± 3.83
Control group 30 cases	Before treatment	1.29 ± 0.11	22.60 ± 5.75	71.67 ± 24.24	169.95 ± 156.22	29.59 ± 5.54
	After treatment	1.29 ± 0.41	20.56 ± 9.99	68.37 ± 27.20	130.95 ± 180.92	35.51 ± 4.75
P value		< 0.0001	0.032	0.217	0.014	0.399

PT, Fib and TBIL were significantly higher in the research group than in the control group after treatment.